About this event
Chemotherapy-induced alopecia (CIA) is likely one of the most distressing aspects for oncology patients and often underestimated by physicians. Among the risk factors for hair loss are treatment-related aspects, as well as patient-related characteristics. Dr. Maria Fortuna, a former Head of the Outpatient Clinic for Rare Skin Cancers at the Policlinico Umberto I in Rome, will explain the course of the disease and how Tricopat can assist in managing this challenging condition. Don't miss it.
Hosted by
